Cargando…
A tetrameric ACE2 protein broadly neutralizes SARS-CoV-2 spike variants of concern with elevated potency
The SARS-CoV-2 receptor angiotensin converting enzyme 2 (ACE2) was previously engineered into a high affinity tetravalent format (ACE2-Fc-TD) that is a potential decoy protein in SARS-CoV-2 infection.We report that this protein shows greatly enhanced binding to SARS-CoV-2 spike proteins of the SARS-...
Autores principales: | Leach, Adam, Ilca, F. Tudor, Akbar, Zulaikha, Ferrari, Mathieu, Bentley, Emma M., Mattiuzzo, Giada, Onuoha, Shimobi, Miller, Ami, Ali, Hanif, Rabbitts, Terence H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8349458/ https://www.ncbi.nlm.nih.gov/pubmed/34375715 http://dx.doi.org/10.1016/j.antiviral.2021.105147 |
Ejemplares similares
-
A super-potent tetramerized ACE2 protein displays enhanced neutralization of SARS-CoV-2 virus infection
por: Miller, Ami, et al.
Publicado: (2021) -
Characterization of a Novel ACE2-Based Therapeutic with Enhanced Rather than Reduced Activity against SARS-CoV-2 Variants
por: Ferrari, Mathieu, et al.
Publicado: (2021) -
Implementing a method for engineering multivalency to substantially enhance binding of clinical trial anti-SARS-CoV-2 antibodies to wildtype spike and variants of concern proteins
por: Leach, Adam, et al.
Publicado: (2021) -
Multimeric antibodies with increased valency surpassing functional affinity and potency thresholds using novel formats
por: Miller, Ami, et al.
Publicado: (2020) -
IgA tetramerization improves target breadth but not peak potency of functionality of anti-influenza virus broadly neutralizing antibody
por: Saito, Shinji, et al.
Publicado: (2019)